Get in Touch

Apr 02, 2015
You are here article details

US FDA’s Alert On Wockhardt: Much Ado About Nothing?

| 5/30/2013 9:02 PM Thursday

Pharma giant Wockhardt has received a strong setback after the US FDA sounded an alert on its Waluj manufacturing facility, after which the stock was hammered by more than 25 per cent in just two trading sessions. The market, however, seems to be overreacting to these developments. Shrikant Akolkar tells us more.

One of the worst things to happen to any stock is for it to get hit by factors which are apparently serious but on deeper exploration seem to be routine. This happens chiefly due to investors’ knee-jerk reaction to news flows which creates humongous negativity around it. One company which has recently been hit by this syndrome is Wockhardt.

We had recommended Wockhardt in DSIJ Vol. 28, Issue # 9 (dated 21 April, 2013) in our cover story ‘Cherry Picking’. The scrip was severely hammered following the recent US FDA alert on its manufacturing facility located in Waluj, Aurangabad district of Maharashtra. In just two trading sessions alone (May 23 and 24, 2013) it lost more than 25 per cent in value. Currently, the stock is down 35 per cent from where we had recommended it. Investors who have acted on our advice would surely be jittery in the wake of such a slide in the stock’s price. What should their future course in this counter be? Should one sell and book losses or wait out the depression? Here are the answers that you would be looking out for.

To start with, the hammering of the stock was a knee-jerk reaction arising out of fears fuelled by a particular event. This fear was accentuated by many other factors that were external to the company. The principal factor among these was the developments in Ranbaxy earlier in the same week.

Ranbaxy, the pharma company now owned by Daichhi Sankyo, pleaded guilty before the United States Department of Justice on compliance related issues in two of its manufacturing facilities. This was in any case weighing heavily on pharma stocks. The alert on Wockhardt’s Waluj facility came immediately after this, and dampened the sentiment on the stock.

What is worth noting is that Ranbaxy had ignored earlier malpractices, the consequences of which it had to bear. Wockhardt, however, had invited the US FDA team to audit its new injectables unit at Waluj. This is what differentiates between the two companies.

Find More Articles on: DSIJ Magazine, Special Report, Stock Recommendations, Fundamental Picks, Product, Large Cap

«« First « Previous |1 2 | Last ››

Related Readings

Top 10 companies with Lowest Foreign Institutional Investors (FIIs) Holding in BSE 100 Companies Exclusive

LatestMost PopularMarket Action


After India gained independence in 1947, it was struggling with multitudes of problems be it socioeconomic problems, such as inequalities in income and low levels of employment or regional imbalances in economic development, weak industrial base, inadequate investments and infrastructure facilities. To get to the bottom of these problems and resolve, public sector undertakings were conceptualized who till date are fulfilling their duties without fail. Today there are 290 central public sector enterprises (CPSEs), out of which 234 are in operation while the rest are under construction. When we study the performance of the CPSEs, during FY14 the total turnover of all the  CPSEs stood at Rs 20,61,866 crore compared to Rs 19,45,814 crore in the previous year, thus showing an increase of 5.96 per cent. The profitability of the profit-making CPSEs also rose by 3.92 per cent and stood at Rs 1,49,164 crore during 2013-14 compared to Rs 1,43,543 crore in 2012-13.

Breaking News

PM Announces ‘Give It Up’ Campaign For LPG Subsidy

Prime Minister Narendra Modi has urged those citizens of India who can afford the high cost of LPG cylinders to give up the related subsidy in the interest of the country. While advocating for self-sufficiency in the energy space, he said that India’s dependence on imported crude should come down by 10 per cent by 2022 when we celebrate our 75 years of independence and it should be down by 50 per cent by 2030. He was speaking at the inaugural session of ‘Urja Sangam-2015’ in New Delhi, which was organised to mark the golden jubilee celebration of ONGC Videsh, Engineers India and Indian Oil’s Barauni Refinery.


The invention of coins, used as a method of payment around the 6th or 5th century BCE, has been enveloped in mystery. Many archaeologists and numismatic scholars are coming to an agreement that the coins were invented independently at three different locations on the Euro-Asian continent comprising Greece, India and China.

Naveen Mathur, Associate Director - Commodities & Currencies, Angel Commodities Broking (P) Ltd. provides a comprehensive picture


The recommendations provided in this column are taken from different market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Dalal Street Investment Journal may or may not subscribe to these recommendations.

Stay On Course To Create Wealth

Any form of investment comes with its own inherent risks but those who understand this and yet remain systematically committed for a long term are the ones who benefit the most

Hemant Rustagi, CEO, Wiseinvest Advisors

Bulls Lead, Bankex Outperforms

The Indian equity markets saw a superb opening for FY16. The Banking and Healthcare stocks helped to pull the benchmark indices on the higher side. Auto and Small-Caps too outperformed and closed up more than 200 points each. Most of the scetoral indices closed on positive mark. As a result the Nifty ended up by 95 points and closed at 8586 whereas Sensex closed 302 points up at 28260.


While the year started on a cheery note with the equity markets soaring high likes kites riding a good breeze, the month of March has seen the expectations of investors come crashing down. Obviously, this has led to a lot of confusion in the minds of investors about whether they should hold on for better times or make a quick exit. DSIJ provides recommendations for five buys and five sells based on technical parameters

Stock Recommendations For Your Portfolio

The scrips in this column have been recommended with a short-term investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.

Stock Pick from Forest Products

Low Priced Scrip is hidden gem, today's underdog, a stock with future potential that is expected to fetch returns within one year. This is a stock picked carefully based on a fundamental analysis of the company. The company recommended as the Low Priced Scrip for this issue is an emerging player in Forest Products.

Stock Pick from IT Consulting & Software

Choice Scrip is a Blue Chip stock pick that is expected to give returns within a six months to one year horizon. The recommendation is based on a fundamental analysis of the company. The company recommended as the Choice Scrip for this issue is a growing entity in IT Consulting & Software.

DSIJ Breakfast News

Start your day with DSIJ Breakfast Roundup, wind up with DSIJ Market Roundup. Register now to get the day’s market outlook, global cues, economic trends, top corporate news delivered straight to your inbox.

mail to

Start your day with DSIJ Breakfast Roundup, wind up with DSIJ Market Roundup. Register now to get the day’s market outlook, global cues, economic trends, top corporate news delivered straight to your inbox.

mail to  *


(* No Research/Stock Queries)
Name :
Email ID :
Cell Number :
Message :